Skip to main content
Premium Trial:

Request an Annual Quote

Takara Bio to Distribute Exiqon Products in Asia

NEW YORK (GenomeWeb News) – Takara Bio will distribute Exiqon's miRCURY LNA products in Asia beginning in January 2013, Exiqon announced today.

Takara will market the microRNA research tools in Japan, China, Hong Kong, South Korea, and India. It also will launch research services in the region using Exiqon's products in December 2012.

"Asia is an important growth market where we expect customers will benefit from our combined efforts with Takara Bio to meet customer demand for high-quality research products," Henrik Pfundheller, SVP of sales and marketing for Exiqon, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.